New research provides a mechanistic map of how genetic mutations disrupt RNA splicing in acute myeloid leukemia.
A retired HGV driver was the first person in the world to take part in a clinical trial to extend the lifespan of blood ...
Treating acute myeloid leukemia (AML) depends on knowing what goes wrong inside cells. A new study suggests that two genetic ...
If you are wondering whether BridgeBio Pharma's recent share price puts it at a stretch or offers room for more, the first step is to look closely at what the current market value actually reflects.
US biotech BostonGene has struck a research collaboration with British pharma AstraZeneca (LSE: AZN) to explore the use of ...
Morning Overview on MSN
Study shows protons in living systems can follow quantum rules
Protons, the positively charged particles that help build every atom in our bodies, are starting to look less like classical ...
From biotech veterans to embattled modalities to a new wave of RNAi therapeutics, BioSpace’s NextGen Class of 2026 emerged ...
AZoLifeSciences on MSN
Dual genetic mutations drive RNA mis-splicing and leukemia progression
Treating acute myeloid leukemia (AML) depends on knowing what goes wrong inside cells. A new study suggests that two genetic ...
Climate change also alters nitrogen in soils and plants, shaping food quality, water safety, and pollution risks worldwide.
The technology, called the Viral-Engineered RNA-based Activation System (VERAS), hijacks the virus's own replication ...
Pediatrician warned children with high triglycerides are likely to develop obesity, insulin resistance and heart disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback